Your browser doesn't support javascript.
COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE).
Baruchel, André; Bertrand, Yves; Boissel, Nicolas; Brethon, Benoit; Ducassou, Stéphane; Gandemer, Virginie; Halfon-Domenech, Carine; Leblanc, Thierry; Leverger, Guy; Michel, Gérard; Petit, Arnaud; Ray-Lunven, Anne-France; Rohrlich, Pierre-Simon; Schneider, Pascale; Sirvent, Nicolas; Strullu, Marion.
  • Baruchel A; Hôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France. Electronic address: andre.baruchel@aphp.fr.
  • Bertrand Y; CHU de Lyon, institut d'hémato-oncologie pédiatrique, Lyon, France.
  • Boissel N; Hôpital Saint-Louis, AP-HP, Université de Paris, unité adolescents et jeunes adultes, Paris, France.
  • Brethon B; Hôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
  • Ducassou S; Groupe hospitalier Pellegrin, unité d'hémato-oncologie pédiatrique, Bordeaux, France.
  • Gandemer V; CHU de Rennes, service d'hémato-oncologie pédiatrique, Rennes, France.
  • Halfon-Domenech C; CHU de Lyon, institut d'hémato-oncologie pédiatrique, Lyon, France.
  • Leblanc T; Hôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
  • Leverger G; Hôpital Armand-Trousseau AP-HP, Sorbonne université, service d'hémato-oncologie pédiatrique, Paris, France.
  • Michel G; CHU la Timone, service d'hématologie pédiatrique, Marseille, France.
  • Petit A; Hôpital Armand-Trousseau AP-HP, Sorbonne université, service d'hémato-oncologie pédiatrique, Paris, France.
  • Ray-Lunven AF; Hôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
  • Rohrlich PS; CHU l'Archet, service d'hémato-oncologie pédiatrique, Nice, France.
  • Schneider P; CHU Charles-Nicolle, service d'hématologie pédiatrique, Rouen, France.
  • Sirvent N; CHU Arnaud-de-Villeneuve, service d'hématologie et oncologie pédiatrique, Montpellier, France.
  • Strullu M; Hôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
Bull Cancer ; 107(6): 629-632, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-618677
ABSTRACT
Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations, even if data for this population are still scarce. They may have to evolve according to the rapid evolution of knowledge on COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic study / Observational study / Prognostic study Language: English Journal: Bull Cancer Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic study / Observational study / Prognostic study Language: English Journal: Bull Cancer Year: 2020 Document Type: Article